US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

AIM AIM ImmunoTech Inc

0.42

0.0051 (1.23%)

21 May 2024 - Cerrado

Retrasado por 15 minutos

Form D/A - Notice of Exempt Offering of Securities: [Amend]

AIM ImmunoTech (AMEX:AIM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas AIM ImmunoTech.

AIM ImmunoTech (AMEX:AIM)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas AIM ImmunoTech.

Noticias sobre AIM ImmunoTech Inc AIM

AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
Lunes 20 de Mayo 2024 (2 días hace) • GlobeNewswire Inc.

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
Jueves 16 de Mayo 2024 (6 días hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Miércoles 15 de Mayo 2024 (6 días hace) • Edgar (US Regulatory)

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
Jueves 9 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martes 7 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 7 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
Lunes 6 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
Lunes 29 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Jueves 25 de Abril 2024 (4 semanas hace) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Jueves 18 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
Lunes 15 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Jueves 11 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Más de AIM ImmunoTech Inc Artículos de Noticias

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones